News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
593,587 Results
Type
Article (46367)
Company Profile (208)
Press Release (547012)
Section
Business (165933)
Career Advice (2522)
Deals (30200)
Drug Delivery (103)
Drug Development (78017)
Employer Resources (148)
FDA (14331)
Job Trends (13115)
News (293628)
Policy (28526)
Tag
Academia (2683)
Alliances (43286)
Alzheimer's disease (1395)
Approvals (14303)
Artificial intelligence (211)
Bankruptcy (318)
Best Places to Work (10742)
Biotechnology (168)
Breast cancer (238)
Cancer (1821)
Cardiovascular disease (144)
Career advice (2107)
CAR-T (136)
Cell therapy (380)
Clinical research (62693)
Collaboration (688)
Compensation (291)
COVID-19 (2591)
C-suite (181)
Data (1689)
Diabetes (219)
Diagnostics (6027)
Earnings (59294)
Employer resources (134)
Events (86154)
Executive appointments (594)
FDA (15246)
Funding (598)
Gene therapy (272)
GLP-1 (687)
Government (4257)
Healthcare (17321)
Infectious disease (2713)
Inflammatory bowel disease (136)
Interviews (524)
IPO (13960)
Job creations (2824)
Job search strategy (1732)
Layoffs (431)
Legal (6035)
Lung cancer (271)
Manufacturing (224)
Medical device (10987)
Medtech (10991)
Mergers & acquisitions (16593)
Metabolic disorders (579)
Neuroscience (1857)
NextGen: Class of 2025 (5961)
Non-profit (4196)
Northern California (2045)
Obesity (306)
Opinion (223)
Patents (178)
People (53209)
Phase I (19752)
Phase II (27580)
Phase III (20669)
Pipeline (798)
Postmarket research (2407)
Preclinical (8241)
Radiopharmaceuticals (251)
Rare diseases (352)
Real estate (4545)
Regulatory (20027)
Research institute (2343)
Resumes & cover letters (391)
Southern California (1771)
Startups (3184)
United States (17585)
Vaccines (644)
Weight loss (222)
Date
Today (120)
Last 7 days (740)
Last 30 days (2582)
Last 365 days (32686)
2025 (5106)
2024 (33420)
2023 (37548)
2022 (48355)
2021 (51962)
2020 (49766)
2019 (42559)
2018 (32213)
2017 (29389)
2016 (28178)
2015 (32753)
2014 (25037)
2013 (20812)
2012 (22143)
2011 (22838)
2010 (20403)
Location
Africa (783)
Arizona (144)
Asia (36049)
Australia (7289)
California (4650)
Canada (1638)
China (404)
Colorado (215)
Connecticut (213)
Europe (82103)
Florida (674)
Georgia (148)
Illinois (413)
Indiana (256)
Maryland (708)
Massachusetts (3478)
Michigan (183)
Minnesota (279)
New Jersey (1299)
New York (1309)
North Carolina (785)
Northern California (2045)
Ohio (150)
Pennsylvania (1010)
South America (1055)
Southern California (1771)
Texas (659)
Utah (147)
Washington State (444)
593,587 Results for "ampliphi biosciences formerly known as targeted genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop and Commercialize Osavampator (formerly NBI-1065845/TAK-653)
January 27, 2025
·
6 min read
Press Releases
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
January 14, 2025
·
7 min read
Press Releases
Targeted Bioscience Unveils Revolutionary Extracellular Vesicle Isolation Kit
January 22, 2025
·
2 min read
Press Releases
Targeted Genomics Receives FDA Clearance for First Direct-to-Consumer Celiac Disease Genetic Health Risk Test
February 17, 2025
·
2 min read
Press Releases
Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators
January 15, 2025
·
4 min read
Business
Ankyra Therapeutics and Jenga Biosciences Announce Exclusive License Agreement for JEN-101
Ankyra Therapeutics and Jenga Biosciences are pleased to announce today an exclusive license agreement to develop and commercialize JEN-101 (formerly known as cANK-101).
March 26, 2024
·
4 min read
Immunology and inflammation
Gilead Continues Diversification Drive With Potential $1.7B Inflammation Pact With LEO
Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 and IL-13 signaling, which in turn are known inflammatory targets.
January 13, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
·
4 min read
·
Dan Samorodnitsky
1 of 59,359
Next
